Literature DB >> 12822849

Burden of care in amyotrophic lateral sclerosis.

Martin J Hecht1, Elmar Graesel, Sebastian Tigges, Thomas Hillemacher, Martin Winterholler, Max-Josef Hilz, Dieter Heuss, Bernhard Neundörfer.   

Abstract

OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a fatal disease with unique demands on patients and carers. PATIENTS AND METHODS: The total burden of care and burden components in 37 ALS carers were measured using validated questionnaires. Furthermore, influencing factors (functional impairment of the patient, additional carers, participation in support groups) were assessed.
RESULTS: The mean total burden of care for ALS was low compared with dementia, mixed neuropsychiatric and internal diseases, but was correlated with functional impairment (P = 0.003). The main burden components were 'personal and social restrictions' and 'physical and emotional problems'. Problem behaviour of the patients was low in general, but was higher in carers participating in support groups (P = 0.002). Carers supported by additional carers had higher strain.
CONCLUSION: The low burden of ALS carers may be caused by the low incidence of problem behaviour in ALS patients. However, if problem behaviour exists, carers participate more often in support groups, indicating the need for assistance. The burden of care increases with the functional impairment. Support for the carers has to start sooner.

Entities:  

Mesh:

Year:  2003        PMID: 12822849     DOI: 10.1191/0269216303pm754oa

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  16 in total

1.  The use of the Burden Assessment Scale with families of a pediatric population.

Authors:  Douglas D Murdoch; Abdul Rahman; Valerie Barsky; Stephen Maunula; David Cawthorpe
Journal:  Community Ment Health J       Date:  2014-03-30

2.  Ten years of riluzole use in a tertiary ALS clinic.

Authors:  Andrew Geronimo; Richard M Albertson; James Noto; Zachary Simmons
Journal:  Muscle Nerve       Date:  2022-04-13       Impact factor: 3.852

3.  Family caregiver perspectives on caring for ventilator-assisted individuals at home.

Authors:  Rachel Evans; Michael A Catapano; Dina Brooks; Roger S Goldstein; Monica Avendano
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

4.  How common is depression among ALS caregivers? A longitudinal study.

Authors:  Judith G Rabkin; Steven M Albert; Lewis P Rowland; Hiroshi Mitsumoto
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 5.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

6.  Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.

Authors:  Michele Peters; Crispin Jenkinson; Helen Doll; E Diane Playford; Ray Fitzpatrick
Journal:  Health Qual Life Outcomes       Date:  2013-06-25       Impact factor: 3.186

7.  Clinical psychology and amyotrophic lateral sclerosis.

Authors:  Francesco Pagnini; Gabriella Rossi; Christian Lunetta; Paolo Banfi; Massimo Corbo
Journal:  Front Psychol       Date:  2010-07-21

8.  The impact on the family carer of motor neurone disease and intervention with noninvasive ventilation.

Authors:  Susan K Baxter; Wendy O Baird; Sue Thompson; Stephen M Bianchi; Stephen J Walters; Ellen Lee; Sam H Ahmedzai; Alison Proctor; Pamela J Shaw; Christopher J McDermott
Journal:  J Palliat Med       Date:  2013-11-16       Impact factor: 2.947

9.  Attitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers.

Authors:  Ralf Stutzki; Ursula Schneider; Stella Reiter-Theil; Markus Weber
Journal:  Front Psychol       Date:  2012-10-25

10.  What are the roles of carers in decision-making for amyotrophic lateral sclerosis multidisciplinary care?

Authors:  Anne Hogden; David Greenfield; Peter Nugus; Matthew C Kiernan
Journal:  Patient Prefer Adherence       Date:  2013-02-28       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.